Galaxy Buds hearing aid feature wins FDA clearance, joining AirPods Pro

With U.S. Food and Drug Administration clearance in hand, the Galaxy Buds hearing aid feature from Samsung turns the Galaxy Buds3 Pro and Galaxy Buds4 Pro into over-the-counter hearing aids for adults 18 and older. Samsung announced the approval this week, becoming the second mainstream earbuds maker after Apple to offer prescription-free hearing assistance in a consumer product. The Hearing Aid and Hearing Test features start rolling out in the United States and select approved markets in the fourth quarter of 2026.

The feature targets people who perceive mild to moderate hearing loss, such as difficulty following conversations in noisy environments. It works without a prescription and without a clinic visit. A built-in Hearing Test, registered with the FDA as Software as a Medical Device (SaMD), uses pure-tone audiometry and returns results in roughly five minutes.

That SaMD registration separates the feature from an ordinary volume booster. The software itself is treated as a medical device, which is why the test carries the same audiometric protocol a clinic would use, compressed into a self-administered session that assesses each ear separately and builds a personalized hearing profile.

Samsung designed the sound personalization around the NAL-NL2 clinical fitting standard, developed with the National Acoustic Laboratories and clinically validated at institutions including Vanderbilt University Medical Center. The same formula underpins professional hearing aid fitting, so the amplification is shaped to the user's individual profile rather than applied as a flat boost.

The earbuds' audio hardware does the heavy lifting. Beamforming concentrates on sounds in front of the wearer, and active noise suppression reduces background interference, which matters most in the noisy settings where mild loss first becomes noticeable. Hearing data, including test results and environmental noise exposure, is fed into Samsung Health, effectively turning the buds into a running hearing-health record.

Compatibility is the main catch. The features require a compatible Galaxy device running One UI 8 or later, and Samsung says no separate app is needed. When the rollout begins, the Hearing Test will live inside the Galaxy Buds menu in Settings.

For Buds3 Pro owners, the capability arrives as a software update on hardware they already own, so the only requirement is a compatible Galaxy phone. The Buds4 Pro will carry the features from launch. Samsung is starting with the United States and will follow with select approved markets, without detailing a schedule beyond the fourth-quarter window.

What the Galaxy Buds hearing aid feature does

Samsung is following the path Apple opened in 2024, when the FDA authorized the hearing aid feature in AirPods Pro. Both companies now ship self-fitting OTC hearing assistance for mild to moderate loss alongside an in-ear hearing test, a capability that did not exist in mainstream earbuds before Apple's move.

The stakes go beyond catching up. Apple held the only FDA-cleared OTC hearing aid in mainstream earbuds for roughly two years. Samsung's clearance removes that exclusive position and gives Android users a first-party option, which matters because the Galaxy Buds features are locked to the Galaxy ecosystem, just as AirPods features are tied to Apple's. The FDA created the OTC hearing category to open hearing care beyond traditional audiology channels, and two major consumer platforms now sit inside it.

With two platforms cleared, feature parity becomes the baseline for the category, and the next rounds of competition will likely focus on test accuracy, fitting quality, and how deeply hearing data integrates with the wider health stack.

What the clearance changes for buyers

For consumers, the practical effect is that premium earbuds can now stand in for a dedicated OTC hearing device in the mild-to-moderate range on two major platforms. That changes the economics of hearing support, because buyers pay for earbuds they would likely purchase anyway instead of adding a separate medical product to the budget. For shoppers comparing earbuds, the Galaxy Buds hearing aid feature adds a deciding factor no competitor without FDA clearance can match.

The five-minute test length matters for adoption. A self-check that fits between meetings is far more likely to be run than one requiring a clinic appointment, which is the barrier the OTC category was designed to remove. Users who run it get a concrete hearing profile plus ongoing noise exposure tracking inside Samsung Health.

The limits deserve attention. The feature covers perceived mild to moderate loss and stops short of severe impairment, and the OTC model still expects users to self-assess. iPhone owners cannot use it because of the Galaxy requirement, and US users wait until the end of the year for the rollout. Storing hearing data in Samsung Health also raises the usual questions about who controls health information collected on a consumer device.

The larger signal is that hearing health is becoming a standard premium-earbuds feature instead of a specialty purchase. With Apple and Samsung both cleared, whether other earbuds makers follow is the open question.

The verdict

For Galaxy users with mild to moderate hearing loss, the Galaxy Buds hearing aid feature is a genuine upgrade: a five-minute self-test, personalized amplification, and no prescription, all delivered through hardware they already own. The costs are the Galaxy-device requirement and the wait until Q4 2026. For everyone else, the clearance still matters because it confirms OTC hearing support is now a mainstream earbuds battleground with two major players. Anyone who suspects mild to moderate loss should run the test when it arrives and treat the result as a starting point, since the feature targets perceived loss rather than diagnosed impairment.

Why this matters

Two years after Apple's AirPods Pro authorization, Samsung's clearance shows that prescription-free hearing support is becoming standard equipment in premium earbuds. That competition should broaden access for the many adults with untreated mild to moderate hearing loss, and it raises the bar for every earbuds maker shipping in 2026 and beyond.

Sources

Samsung's Hearing Aid Feature on Galaxy Buds Cleared by FDA

Related Articles

• Samsung Refines Wearable Comfort Using New Computational Design Methodology
• Apple Tests New Camera-Equipped AirPods for 2026 Launch
• Samsung Unveils New Galaxy Watch AI Health Features for Enhanced Wellness Tracking

✔Human Verified

Researched and cross-referenced against primary sources by the Bytevyte editorial team. This article was generated with the assistance of artificial intelligence and reviewed by the Bytevyte editorial team.